- Home
- COLL vs DSGR Comparison
COLL vs DSGR Comparison
Compare COLL & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | DSGR |
|---|---|---|
| Founded | 2002 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | COLL | DSGR |
|---|---|---|
| Price | $34.50 | $19.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $50.83 | $35.00 |
| AVG Volume (30 Days) | ★ 400.6K | 112.9K |
| Earning Date | 05-28-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 212.50 |
| EPS | ★ 1.73 | 0.18 |
| Revenue | $780,567,000.00 | ★ $1,980,023,000.00 |
| Revenue This Year | $6.07 | $7.12 |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ $20.21 | $110.03 |
| Revenue Growth | ★ 23.62 | 9.75 |
| 52 Week Low | $23.23 | $19.71 |
| 52 Week High | $50.79 | $33.80 |
Technical Indicators
Market Signals| Indicator | COLL | DSGR |
|---|---|---|
| Relative Strength Index (RSI) | 16.51 | 12.46 |
| Support Level | $34.30 | N/A |
| Resistance Level | $36.20 | $29.22 |
| Average True Range (ATR) | 1.59 | 1.27 |
| MACD | -0.70 | -1.07 |
| Stochastic Oscillator | 2.18 | 2.06 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.